Pinnacle Medicines
PrivateLast Round
Series B
Mar 26, 2026
Total Funding Raised
$134M
Momentum Score
50 /100
Company Overview
Pinnacle Medicines is a biotechnology company that develops oral peptide therapeutics designed to deliver biologic-level efficacy with the convenience of oral dosing for immunology and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinnacle Medicines Comps
Public and private peers based on sector, stage, and business model.
Pinnacle Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 26, 2026 |
Pinnacle Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| OrbiMed | Series B, Series A |
| Logos Capital | Series B |
| Foresite Capital | Series B |
| Lilly Asia Ventures | Series B |
| Hankang Capital | Series B |
| Qiming Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
$89M round completed.
Pinnacle Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pinnacle Medicines's valuation, stock price, and market status.
